July 1, 2020 / 1:16 AM / 11 days ago

BRIEF-Telix Pharma Gets U.S FDA Breakthrough Designation For Tlx250-Cdx Product

July 1 (Reuters) - Telix Pharmaceuticals Ltd:

* FDA GRANTS BREAKTHROUGH DESIGNATION FOR TLX250-CDX PRODUCT

* US FDA GRANTED BREAKTHROUGH THERAPY DESIGNATION FOR RENAL CANCER IMAGING PRODUCT Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below